Remodelin can significantly inhibit the expression levels of CDC6 in prostate cancer cells and the proliferation ability of prostate cancer cells in vitro, regardless of whether the cells were treated with androgen-removed or androgen-treated cells (Figure 5A,B). This evidence concerns the gene CDC6 and Familial prostate cancer.